CHOLANGIOCARCINOMA, INTRAHEPATIC
Clinical trials for CHOLANGIOCARCINOMA, INTRAHEPATIC explained in plain language.
Never miss a new study
Get alerted when new CHOLANGIOCARCINOMA, INTRAHEPATIC trials appear
Sign up with your email to follow new studies for CHOLANGIOCARCINOMA, INTRAHEPATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take on bile duct cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new cell therapy for people with advanced biliary tract cancer (bile duct or gallbladder cancer) that has not responded to standard treatments. The therapy uses the patient's own immune T cells, enhanced with a protein called CD160 to better target …
Matched conditions: CHOLANGIOCARCINOMA, INTRAHEPATIC
Phase: PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Liver transplant hope for bile duct cancer patients
Disease control Recruiting nowThis study looks at whether a liver transplant can help people with a certain type of advanced bile duct cancer that hasn't spread. Participants will first receive chemotherapy to control the cancer, then undergo a liver transplant. The goal is to see if this approach helps them …
Matched conditions: CHOLANGIOCARCINOMA, INTRAHEPATIC
Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC